Dr. Bastiaens is a psychiatrist who specializes in treating people suffering from depression and anxiety spectrum disorders (Obsessive Compulsive Disorder, Generalized Anxiety, Panic), among other disorders. He maintains an empathetic and professional style with people, listening carefully to understand patients and their individual experience. He wants his patients to feel comfortable, heard, and supported as they work together to develop an optimal treatment plan.
During medical school, Dr. Bastiaens became interested in psychiatry after recognizing how debilitating mental health issues can be for people, as well as the positive impact that treatments can make. He appreciates the meaningful and rewarding connections he develops and maintains with patients.
Dr. Bastiaens also has a great passion for the brain and neuroscience – how electrical and chemical impulses can direct our thoughts, feelings, and functioning. He sees psychiatry as a rapidly growing science incorporating therapy, medications, and interventional modalities, and is glad to be a part of the movement and momentum.
He is a strong proponent of Transcranial Magnetic Stimulation (TMS), a newer advancement in psychiatry that can often help people when medications and therapy are not enough. He appreciates that it is well-tolerated, specifically tailored to each individual, and often a more precise treatment when compared to other strategies. As TMS utilizes neuroscientific principles of brain connectivity, it is expanding in the symptoms and illnesses it can treat at the forefront of the psychiatric field. Dr. Bastiaens looks forward to participating in this growth and helping patients find resilience and recovery.
He joined TMS Health Solutions in the Fall of 2018.
Dr. Bastiaens finds the Bay Area to be an amazing combination of outdoor and city life. From phenomenal restaurants to breathtakingly scenic hikes, he enjoys the diversity of offerings and activities in and around San Francisco. He continues to pursue work outside of work by reading scientific literature and keeping up to date on the latest advances, contributing to his own psychiatric practice and tackling the struggle of mental illness.
Dr. Bastiaens graduated from Northwestern University in Chicago with a BA in Economics and Psychology, magna cum laude. When first entering college, he had suspected he would pursue a path in the humanities. While still maintaining a love of the humanities, he soon realized he had an interest and aptitude in the sciences. After volunteering as an Emergency Medical Technician (EMT) in college, his pursuit of healthcare was sealed.
He graduated from Cornell Medical School on the upper east side of Manhattan. He honed his skills in critical thinking and enjoyed the breadth of study. After earning his medical doctorate, he came to University of California, San Francisco for his residency in psychiatry. He helped develop a curriculum and pathway for residents to train in interventional psychiatry (including TMS). He eventually became Chief Resident at the San Francisco VA, treating veterans and teaching junior residents while building his leadership and mentorship skills.
Dr. Bastiaens experience has a depth and breadth that includes work in the Zuckerberg San Francisco General Hospital, where he has helped support the city’s marginalized population. He particularly enjoyed his time working at the VA, with its mission of helping those who have served our country. He has also spent time moonlighting in emergency departments in San Francisco. His experience has assisted a wide swath of patients, their varied mental illnesses, and the common goal toward achieving recovery and remission.
Bastiaens J, Saunders R, Esuf M, Bermudes R. Assessment of the Separation of Responders and Non-
Responders to rTMS for Treatment Refractory MDD. Presented at the Clinical TMS Society Annual Meeting as a Poster and Oral Presentation, New York, New York, May 11-13, 2018.
Bastiaens J, Saunders R, Esuf M, Bermudes R. Efficacy of rTMS for Treating Refractory Major Depression
in Clinical Practice. Poster presented at the Clinical TMS Society Annual Meeting, New York, New York, May 11-13, 2018.
Bastiaens J, Saunders R, Esuf M, Delucchi K, Bermudes R. Effectiveness of Adjunctive rTMS for Treatment
Resistant Depression in a Commercially Insured Population. Poster presented at the Clinical TMS Society Annual Meeting, San Diego, California, May 18-20, 2017.
Vidrine R, Bastiaens J, Saunders R, Hung E. Interventional Psychiatry Area of Distinction: A Novel Way to
Enhance Resident Exposure and Knowledge Base in the Field of Neuromodulation Despite a Lack of Robust Clinical Services. Poster presented at the Clinical TMS Society Annual Meeting, San Diego, California, May 18-20, 2017.
Bastiaens J, Bourgeois J. Psychiatric Disorders, Treatment, and Association with Delirium. In J. Bourgeois
(Ed.), Chapter 9 (143-162). Delirium: Prevention, Symptoms, and Treatment. Nova Science Publishers, 2017.
Hargrave A, Bastiaens J, et al. Validation of a Nurse-Based Delirium-Screening Tool for Hospitalized Patients. Psychosomatics 58.6 (2018): 594-603.
Hargrave A, Bastiaens J, et al. Validation of a Nurse-Based Delirium Screening Tool for Hospitalized Patients.
Poster presented at the American Academy of Neurology annual meeting, April, 2016
Poster presented at the UCSF Inquiry Symposium, May, 2016
Poster presented at the International Anesthesia Research Society, May, 2016
Presented at the American Delirium Society as an Oral Presentation, June, 2016
Bastiaens J, Agarkar S. A Case of Poor Insight in Schizophrenia: How much do we know? Psychiatric Annals 44.5 (2014): 207-210.
Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ. Prospective Cohort Study of Impulse Control Disorders in Parkinson’s disease. Movement Disorders 28.3 (2013): 327-333.
Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ. Prospective Cohort Study of Impulse Control Disorders in Parkinson’s disease. Presented at the American Academy of Neurology annual meeting as a Poster and Oral presentation, New Orleans, Louisiana, April, 2012.
Bastiaens L, Bastiaens J. Severely mood-disordered youth respond less well to treatment in a community clinic than youth with bipolar disorder. Poster presented at the European Congress of Psychiatry, Lisbon, Portugal, January, 2009
Bastiaens L, Bastiaens J. Severely mood-disordered youth respond less well to treatment in a
community clinic than youth with bipolar disorder. Psychiatry 5.10 (2008):37–41.